Remdesivir, Favipiravir and Dexamethasone Linked to SARS CoV-2 Variants of Interest and Concern: Could Molnupiravir and SARS CoV-2 Mass Vaccination Programs Add Oil to The Fire?
Résumé
SARS CoV-2 Variants of interest and concern are considered a real challenge to our medical efforts to stem down COVID-19. We suggest that these variants evolve simultaneously in different countries though detected first in some while postulating that some drugs might share in their evolution and recommending that SARS CoV-2 vaccination, probably the subunit not the gene based or the inactivated ones, should be offered only to the high-risk groups after an informed personalized risk benefit ratio has been weighed.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 05/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →